Atherosclerotic lesions are characterized by the accumulation of abundant lipids and chronic inflammation. Previous researches have indicated that macrophage-derived lipoprotein lipase (LPL) promotes atherosclerosis progression by accelerating lipid accumulation and proinflammatory cytokine secretion. Although apelin-13 has been regarded as an atheroprotective factor, it remains unclear whether it can regulate the expression of LPL. The aim of this study was to explore the effects of apelin-13 on the expression of LPL and the underlying mechanism in THP-1 macrophage-derived foam cells. Apelin-13 significantly decreased cellular levels of total cholesterol, free cholesterol, and cholesterol ester at the concentrations of 10 and 100 nM. ELISA analysis confirmed that treatment with apelin-13 reduced pro-inflammatory cytokine secretion, such as interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α). It was also found that apelin-13 inhibited the expression of LPL as revealed by western blot and real-time PCR analyses. Bioinformatics analyses and dual-luciferase reporter assay indicated that miR-361-5p directly downregulated the expression of LPL by targeting the 3′UTR of LPL. In addition, apelin-13 + miR-361-5p mimic significantly downregulated the expression of LPL in cells. Finally, we demonstrated that apelin-13 downregulated the expression of LPL through activating the activity of PKCα. Taken together, our results showed that apelin-13 downregulated the expression of LPL via activating the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells, leading to inhibition of lipid accumulation and proinflammatory cytokine secretion. Therefore, our studies provide important new insight into the inhibition of lipid accumulation and pro-inflammatory cytokine secretion by apelin-13, and highlight apelin-13 as a promising therapeutic target in atherosclerosis.
Introduction
Apelin is an adipokine that has been identified as an endogenous ligand for the orphan receptor APJ [1] . Although the apelin/APJ system is primarily atheroprotective [2] , it can also promote the development of atherosclerosis [3] . Apelin-13, secreted primarily by adipose tissue, is the most important member of the apelin family. Apelin-13 is expressed in various tissues and has important biological effects, especially in the cardiovascular system [4, 5] . There has been a large body of evidence that the apelin-13 is essential for maintenance of normal cardiovascular functions [6, 7] . As a potent regulator of myocardial contractility, this pathway has been reported to protect against myocardial ischemia-reperfusion (I/R) injury [8] . Recently, several studies have demonstrated that administration of apelin-13 markedly reduces the area of atherosclerotic plaques in apolipoprotein E (apoE) knockout mice [2, 9, 10] . However, the molecular mechanisms by which apelin-13 antagonizes atherogenesis have not been fully understood.
Lipoprotein lipase (LPL) is secreted primarily by the parenchymal cells of muscle and adipose tissues, which can hydrolyze triglyceride (TG) into free fatty acids (FFAs) and glycerol [11] . Overexpression of LPL in the macrophages accelerates the formation of foam cells and amplifies inflammatory response, leading to the development of atherosclerosis [12] . Conversely, knockdown of LPL in macrophages results in decreased lipid accumulation [13] . MicroRNAs (miRNAs) are noncoding small RNAs, which are 18-24 nucleotides in length, working at the post-transcriptional level of the gene expression regulation [14] . Recently, our group found that miR-590, miR-186, and miR-134 are able to regulate LPL expression in THP-1 macrophages [15] [16] [17] . It has been reported that miR-361-5p, a polyphenic miRNA, is involved in the development of cardiovascular diseases [18, 19] . Nevertheless, it is not clear whether miR-361-5p is able to modulate LPL expression.
The aim of the present research was to investigate the effects of apelin-13 on LPL expression and the underlying mechanisms. Our results showed that administration of apelin-13 downregulated LPL expression via activating the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells, leading to decreased lipid accumulation and pro-inflammatory cytokine secretion. Our findings collectively support the use of apelin-13 as a novel therapeutic agent for atherosclerosis.
Materials and Methods
Cell culture and treatment THP-1 monocytes were obtained from the American Type Culture Collection (ATCC, Manassas, USA) and cultured in RPMI 1640 (Sigma, St Louis, USA) supplemented with 10% (v/v) fetal bovine serum (5% CO 2 , 37°C). Cells were differentiated into macrophages following treatment with 100 nM phorbol 12-myristate 13-acetate (PMA) for 48 h. Subsequently, these cells were exposed to 50 μg/ml oxidized low-density lipoprotein (ox-LDL) (Luwen Biotechnologies, Shanghai, China) for 48 h in a serum-free medium to induce foam cell formation.
Cells were treated with 0, 1, 10, and 100 nM apelin-13 (Phoenix Pharmaceuticals, Burlingame, USA) for 0, 6, 12, and 24 h. To determine the involvement of APJ, PKCα, and miR-361-5p in apelin-13-stimulated LPL expression, cells were pretreated with PTX (Seikagaku Co, Tokyo, Japan), PKCα siRNA (Santa Cruz Biotechnology) or miR-361-5p inhibitor (Ribobio, China) before the incubation with 100 nM apelin-13.
The isolation of RNA and real-time quantitative PCR
Total RNA from THP-1 macrophage-derived foam cells was isolated by using RNeasy Mini Kit (Qiagen, Valencia, Germany) according to the instructions of the manufacturer. The qPCR was conducted with LightCycler Run 5.32 Real-Time PCR System (Roche, Beijing, China) a system of qPCR utilizing SYBR Green Master Mix. The analyses of all qPCR products were conducted and presented to produce a single DNA duplex. The sequences of the real-time PCR primers were as follows: LPL, forward 5′-GGACTGAGAGTGAAACCCATAC-3′ and reverse 5′-TGTGGAAACTTCAGGCAGAG-3′; β-actin, forward 5′-CACTCTTCCAGCCTTCCTTC-3′ and reverse 5′-GTACAGGT CTTTGCGGATGT-3′; and miR-361-5p, 5′-AATAGTCTTAGA GGTCCCCATG-3′. Quantitative measurements were determined using the method of ΔΔCt and GAPDH expression was used as the internal control.
Western blot analyses
The analysis of western blot was conducted as described previously [17, 18] . After exposure to RIPA buffer with protease inhibitor cocktail (Sigma), the extraction of proteins was performed by centrifugal separation (12,000 g, 4°C, 10 min). These proteins were separated by 10% SDS-PAGE and then transferred onto a nitrocellulose membrane. After being blocked with 5% (w/v) fat-free dry milk for 4 h, the membranes were incubated overnight with a primary antibodies including anti-LPL antibody (1:100; Biovision, San Francisco, USA) and anti-PKCα rabbit mAb (1:1000; Cell Signaling, Shanghai, China), and then with horseradish peroxidase-conjugated secondary antibody (1:5000; Proteintech, Chicago, USA) for 2 h. The proteins were visualized using an ECL Plus western blotting detection system (Amersham Biosciences, Shanghai, China). 
Transfection of siRNA

HPLC analysis
The analysis of HPLC was performed as described previously [20] . Cells were detached in PBS supplemented with 1% EDTA (Sigma). The analysis of sterols was performed using HPLC (Model 2790; Waters, Milford, USA). A photodiode array detector (Model 996; Waters) equipped with a 4-μl cell was applied to monitor the sterols. The analysis of cholesterol and cholesteryl esters was performed after elution with acetonitrile-isopropanol 30:70 (v/v) and absorbance at 210 nm was monitored. Total Chrome software from PerkinElmer (Shanghai, China) was used to analyze data.
ELISA
ELISA was performed to detect the secretion of pro-inflammatory cytokines. The concentrations of interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) was measured using the corresponding kits (ABCAM, Shanghai, China) according to the instructions of the manufacturer. THP-1 macrophage-derived foam cells were divided into five groups and cultured in the medium at 37°C containing BSA, 0, 1, 10, or 100 nM apelin-13 for 24 h. HPLC was performed to determine the levels of cellular total cholesterol (TC), free cholesterol (FC), and cholesterol ester (CE). The results are expressed as the mean ± SD from three independent experiments. * P < 0.05 vs control group. THP-1 macrophage-derived foam cells were divided into five groups and cultured in the medium at 37°C containing BSA or 100 nM apelin-13 for indicated time. The levels of cellular total cholesterol (TC), free cholesterol (FC), and cholesterol ester (CE) were determined by HPLC. The results are expressed as the mean ± SD from three independent experiments. * P < 0.05 vs control group. 
Bioinformatics prediction
The miRDB (http://mirdb.org/miRDB/) is a database for miRNA target prediction and functional annotations across species. Both the microRNA (http://www.microrna.org/microrna/) and TargetScan (http://www.targetscan.org/) were used to identify miR-361-5p binding sites. The former is an online resource to predict miRNA targets THP-1 cells were transfected with miR-361-5p mimic, the luciferase constructs of the wild-type LPL-3′UTR (LPL-3′UTR-wt) or a mutated LPL-3′UTR (LPL-3′UTR-mut). The luciferase activity was then analyzed. (E, F) LPL protein and mRNA levels were measured by western blot analysis and RT-PCR in THP-1 macrophages treated with scrambled miR-361-5p, apelin-13, apelin-13 + miR-361-5p mimic or apelin-13 + miR-361-5p inhibitor, respectively. (G-I) THP-1 macrophage-derived foam cells were treated with scrambled miR-361-5p, apelin-13, apelin-13 + miR-361-5p mimic or apelin-13 + miR-361-5p inhibitor, respectively. The levels of IL-6, IL-1β and TNF-α were measured by the ELISA. All the results are expressed as the mean ± SD from three independent experiments. * P < 0.05 vs control group; # P < 0.05 vs apelin-13 group.
and target downregulation scores. The latter is a tool resource to predict biological targets of miRNAs by searching for the presence of conserved sites that match the seed region of miRNAs. In addition, the RNAhybrid software (http://bibiserv.techfak.uni-bielefeld. de/bibi/Tools.html) was used to search for the minimum free energy hybridization of RNAs.
3′UTR luciferase reporter assay
MiR-361-5p mimic/inhibitor were purchased from Ribobio. MiR-361-5p mimics were transfected into HEK293T and THP-1 macrophages (40 nM, 24 h) with RiboFECT™ CP reagent (Ribobio) according to the manufacturer's instructions. MiR-361-5p mimic is doublestranded RNA with chemical modifications which can enhance endogenous miR-361-5p function. MiR-361-5p inhibitor is singlestranded RNA with chemical modifications that can specifically inhibit the endogenous miR-361-5p molecules. QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, USA) was used to mutate the miR-361-5p seed sequence located in the 3′UTR of LPL mRNA to generate mutant LPL 3′UTR luciferase reporter. Reporter vector containing the wildtype or mutated 3′UTR was transfected with miR-361-5p mimic or mimic-neg (Applied Biosystems) into cells using Lipofectamine 2000. Finally, the Dual-Luciferase Reporter Assay System (Promega, Shanghai, China) was used to analyze luciferase activities. Data were normalized for transfection efficiency by dividing firefly luciferase activity with that of Renilla luciferase.
Statistical analysis
All data were obtained from at least three independent experiments. Results are expressed as the mean ± SD. SPSS 13.0 software was used for statistical analyses. Student's t-test and one-way ANOVA were used to analyze all data. P-values < 0.05 were considered of statistically significant difference.
Results
Apelin-13 reduces lipid accumulation and proinflammatory cytokine secretion in THP-1 macrophagederived foam cells
Lipid accumulation is a key driver of atherosclerosis [21] . Therefore, the intracellular cholesterol contents in THP-1 macrophage-derived foam cells were measured by HPLC. As shown in Tables 1 and 2 , treatment with apelin-13 decreased the contents of TC, FC, and CE in a concentration-and time-dependent manner. Like lipid accumulation, excessive inflammatory response plays an important role in promoting the development of atherosclerosis. Next, the levels of pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in THP-1 macrophage-derived foam cells were analyzed by ELISA. Our results showed that apelin-13 markedly reduced the levels of IL-6, IL-1β, and TNF-α in a concentrationand time-dependent manner (Fig. 1A-F) .
LPL is involved in inhibiting lipid accumulation and pro-inflammatory cytokine secretion mediated by apelin-13
Given that macrophage LPL is a contributor to lipid accumulation and pro-inflammatory cytokine secretion [22] , we thus explored whether apelin-13 affects macrophage LPL expression. The results showed that apelin-13 reduced LPL mRNA and protein levels in a time-and concentration-dependent manner in THP-1 macrophagederived foam cells ( Fig. 2A-D) . To determine the role of LPL in the inhibition of lipid accumulation and pro-inflammatory cytokine secretion mediated by apelin-13, THP-1 macrophage-derived foam cells were treated with apelin-13 and/or pcDNA3.1-LPL. As expectedly, apelin-13 alone attenuated intracellular TC, FC, and CE contents as well as IL-6, IL-1β, and TNF-α levels, which was abolished by LPL overexpression ( Table 3 and Fig. 2E-G) . Collectively, the findings suggest that apelin-13 inhibits lipid accumulation and proinflammatory cytokine secretion through downregulation of LPL expression in THP-1 macrophage-derived foam cells.
MiR-361-5p is required for apelin-13-induced downregulation of LPL expression
It has been suggested that miR-361-5p is associated with cardiovascular disease [19, 23] . Based on this observation, we took advantage of the miRDB database and found that miR-361-5p is evolutionarily conserved in different species (Fig. 3A) . A potential binding site for miR-361-5p was identified in the 3′UTR of human LPL mRNA using both the microRNA and TargetScan (Fig. 3B) . The RNAhybrid software showed a lower free energy score at −14.2 kcal/mol in human beings (Fig. 3C) . Furthermore, transfection with miR-361-5p mimic markedly decreased the luciferase activity of LPL 3′UTR in HEK 293T cells (Fig. 3D) . These results suggest that LPL is a target gene of miR-361-5p.
Subsequently, we investigated whether miR-361-5p was involved in the inhibitory effects of apelin-13 on LPL expression, lipid accumulation, and pro-inflammatory cytokine secretion. THP-1 macrophage-derived foam cells were treated with apelin-13 and/or miR-361-5p inhibitor. Our results revealed that cells treated with miR-361-5p inhibitor reverse apelin-13-induced downregulation of LPL expression, lipid accumulation, and pro-inflammatory cytokine secretion (Table 4 and Fig. 3E-I ). These findings indicate that apelin-13 may suppress the expression of LPL in miR-361-5p-dependent manner in THP-1 macrophage-derived foam cells. Human THP-1 macrophage-derived foam cells were treated with scramble, apelin-13, apelin-13+miR-361-5p mimic or apelin-13+miR-361-5p inhibitor, respectively. TC, total cholesterol; FC, free cholesterol; CE, cholesterol ester. Lipid level was determined by HPLC. Data are expressed as the mean ± SD from three independent experiments. * P < 0.05 vs control group; # P < 0.05 vs apelin-13 group.
Apelin-13-induced downregulation of LPL expression is dependent on the APJ/PKCα signaling
It has been well established that PKCα is a downstream target protein of apelin-13 [24, 25] . We presumed that PKCα might be required for apelin-13-induced downregulation of LPL expression in THP-1 macrophage-derived foam cells. Thus, siRNA technique was used to reduce PKCα levels. Our results showed that PKCα siRNA significantly decreased PKCα protein when compared with control cells (Fig. 4A) . Apelin-13 treatment increased miR-361-5p levels, downregulated LPL expression, and inhibited lipid accumulation and pro-inflammatory cytokine secretion, whereas these effects were reversed in response to treatment with PKCα siRNA (Table 5 and Fig. 4B-G) . Subsequently, pertussis toxin (PTX) that blocks Gi/o proteins was used to determine whether APJ is implicated in the effects of apelin-13 on LPL expression, lipid accumulation, and proinflammatory cytokine secretion. Our results showed that apelin-13 upregulated PKCα, increased miR-361-5p expression, suppressed lipid accumulation and pro-inflammatory cytokine secretion, but downregulated LPL expression, which was abolished by PTX (Table  6 and Fig. 5H-G) . These results suggest the involvement of the APJ/ PKCα signaling cascade in apelin-13-induced downregulation of LPL expression in THP-1 macrophage-derived foam cells.
Discussion
Atherosclerosis is the pathological basis of cardiovascular diseases [26] . It has been reported that overexpression of macrophage LPL promotes lipid accumulation and pro-inflammatory cytokine secretion, two critical events in the atherogenesis [27] . Several studies have indicated that apelin-13 promotes cholesterol efflux in macrophages with antiatherosclerotic effect [6, 7] . Although apelin-13 can protect against atherosclerosis, its effects on LPL expression are still poorly understood. In this study, we provided experimental evidence that apelin-13 downregulated LPL expression through activation of the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophagederived foam cells, leading to decreased pro-inflammatory cytokine secretion and lipid accumulation. Thus, apelin-13 might contribute to the inhibition of the development of atherosclerosis in vivo. This possibility still needs further investigation. Accumulating evidence suggests that apelin-13 plays important roles in attenuating lipid accumulation and inflammation [28, 29] . Moreover, apelin-13 prevents insulin-stimulated lipid accumulation in adipocytes by activating the phosphatidylinositol 3-kinase (PI3K) /aquaporin 7(AQP7) signaling pathway [28] . Macrophage LPL, as a non-enzymatic molecular bridge between proteoglycans and lipoprotein receptors, contributes to atherogenic lipoprotein uptake and inflammatory factor expression [30] . In this study, we explored whether apelin-13 reduced lipid accumulation and pro-inflammatory cytokine secretion by targeting LPL. Our current study showed that pcDNA3.1-LPL reversed apelin-13-induced reduction of lipid accumulation and secretion of pro-inflammatory cytokines. Thus it is possible that apelin-13 affects LPL expression, subsequently regulates lipid accumulation and secretion of pro-inflammatory cytokines in THP-1 macrophage-derived foam cells.
MiR-361 is located on Xq21.2 in an intron between exon 9 and 10 of CHM/choroideremia (RAB escort protein 1), and contains two mature miRNA species: miR-361-3p and the predominant miR-361-5p [31] . The latter regulates a number of cellular processes, including cell growth and differentiation, apoptosis, autophagy, and stress response [32] . It has been reported that the miR-361-5p has multiple target genes, such as transforming growth factor beta receptor 1(TGFBR1), insulin-like growth factor 1(IGF1), interleukin-10 (IL-10), and vascular endothelial growth factor A (VEGFA) [33] . In this study, we identified LPL as a novel target gene of miR-361-5p. Moreover, apelin-13 treatment markedly increased miR-361-5p levels, and miR-361-5p inhibitor fully reversed apelin-13-induced downregulation of LPL expression. Therefore, apelin-13 may inhibit LPL expression in miR-361-5p-dependent manner in THP-1 macrophage-derived foam cells.
PKCα is a nodal regulator in some intracellular signaling networks [34] . It is composed of modular domains that interact with each other to dynamically regulate spatial-temporal functions. Recently, our group reported that administration of apelin-13 can activate PKCα in THP-1 macrophage-derived foam cells [7] . In this study, we observed that treatment with siRNA for PKCα abolished the upregulation of miR-361-5p expression and downregulation of LPL expression mediated by apelin-13, suggesting a significant role of PKCα in regulating LPL. PTX is a Gi/Go-specific inhibitor, which uncouples Gi/Go proteins from their receptors by ADPribosylation [35] . We found that administration of PTX reversed the effects of apelin-13 on PKCα phosphorylation and miR-361-5p and LPL expression. All the above results indicate that the APJ/ PKCα pathway plays a key role in apelin-13-mediated downregulation of LPL expression.
In conclusion, we demonstrated that apelin-13 activates PKCα and then increases miR-361-5p levels, leading to downregulation of LPL expression and subsequent attenuation of lipid accumulation and pro-inflammatory cytokine secretion in THP-1 macrophagederived foam cells (Fig. 6) . These findings provide new insights into the atheroprotective function of apelin-13. With continuing efforts, developing apelin-13 into a novel therapeutic agent may offer benefits for the treatment of atherosclerotic disease.
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